Clinical Endocrinology 1981-09-01

Endocrine effects of domperidone: a peripheral dopamine blocking agent.

G M Brown, H Verhaegan, T B Van Wimersma Greidanus, J Brugmans

Index: Clin. Endocrinol. (Oxf.) 15(3) , 275-82, (1981)

Full Text: HTML

Abstract

In the present study, effects of domperidone, a peripheral dopamine blocking agent, on prolactin and growth hormone were examined to determine whether dopamine regulation of these hormones involved structures external to the blood-brain barrier. A clearcut elevation in prolactin was produced by domperidone. GH response to apomorphine was partially blocked by domperidone.

Related Compounds

Related Articles:

CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.

2013-12-01

[Purinergic Signal. 9(4) , 609-19, (2013)]

Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions.

1985-02-22

[Pharm. Weekbl. Sci. 7(1) , 1-9, (1985)]

Dynamic cation-exchange systems for the separation of drugs derived from butyrophenone and diphenylpiperidine by high-performance liquid chromatography and applied in the determination of halopemide in plasma.

[J. Chromatogr. A. 164(2) , 177-85, (1979)]

Effects of halopemide on potassium-induced release of radiolabeled neurotransmitters from rat cerebrocortical slices in vitro.

1980-09-01

[Arch. Int. Pharmacodyn. Ther. 247(1) , 43-58, (1980)]

Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.

1986-01-01

[Psychopharmacology 89(1) , 108-12, (1986)]

More Articles...